Rosetta receives NOA for U.S. patent app

|About: Rosetta Genomics Ltd. (ROSG)|By:, SA News Editor

The USPTO issues a Notice of Allowance for Rosetta Genomics' (ROSG +0.8%) patent application 13/977,797 entitled "Compositions and Methods for Treatment of Ovarian Cancer." The patent relates to the inhibition of miR-210 for the treatment of ovarian cancer.

The patent, when issued, will be the company's 33rd in the U.S. It has 27 patent applications pending.